HCM
LABU icon

Hollencrest Capital Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Hollencrest Capital Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.47K Hold
29
– – ﹤0.01% 836
2026
Q1 		$4.82K Buy
29
+6
+26% +$985 ﹤0.01% 926
2025
Q4 		$3.67K Buy
23
+7
+44% +$961 ﹤0.01% 948
2025
Q3 		$1.5K Hold
16
– – ﹤0.01% 1016
2025
Q2 		$911 Hold
16
– – ﹤0.01% 1024
2025
Q1 		$976 Sell
16
-28
-64% -$2.39K ﹤0.01% 1017
2024
Q4 		$3.96K Buy
44
+28
+175% +$3.29K ﹤0.01% 922
2024
Q3 		$2.06K Buy
16
+6
+60% +$783 ﹤0.01% 954
2024
Q2 		$1.13K Buy
+10
New +$1.07K ﹤0.01% 977

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

Hollencrest Capital Management's LABU Position: Q2 2026 in Review

Hollencrest Capital Management held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q2 2026 at 29 shares worth $8.47K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Hollencrest Capital Management first reported a position in LABU in Q2 2024 and has held it in 9 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Hollencrest Capital Management held 29 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $8.47K as of Q2 2026.
  • Hollencrest Capital Management left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #836 holding.
  • Hollencrest Capital Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2024 and has held it in 9 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.